Forte Biosciences, Inc.

SecurityFBRX / Forte Biosciences, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership582,263 shares
Latest Disclosed Value $ 15,878,312
Vanguard Group Inc reports 2.74% increase in ownership of FBRX / Forte Biosciences, Inc.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 582,263 shares of Forte Biosciences, Inc. (US:FBRX) valued at $15,878,312 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 566,741 shares of Forte Biosciences, Inc.. This represents a change in shares of 2.74% during the quarter. The current value of the position is $9,717,969 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F FORTE BIOSCIENCES COM NEW 34962G208 582,263 15,522 2.74 15,878 86.78 0.0002
2025-11-07 2025-09-30 13F FORTE BIOSCIENCES COM NEW 34962G208 566,741 79,822 16.39 8,501 35.04 0.0001
2025-08-11 2025-06-30 13F FORTE BIOSCIENCES COM NEW 34962G208 486,919 397,968 447.40 6,296 812.32 0.0001
2025-05-09 2025-03-31 13F FORTE BIOSCIENCES COM NEW 34962G208 88,951 62,557 237.01 690 15.19 0.0000
2025-02-11 2024-12-31 13F FORTE BIOSCIENCES COM NEW 34962G208 26,394 0 0.00 599 307.48 0.0000
2024-11-13 2024-09-30 13F FORTE BIOSCIENCES COM NEW 34962G208 26,394 -964,367 -97.34 148 -87.84 0.0000
2020-05-15 2020-03-31 13F TOCAGEN COM 888846102 990,761 -2,640 -0.27 1,209 128.11 0.0001
2020-02-14 2019-12-31 13F TOCAGEN COM 888846102 993,401 -10,716 -1.07 530 -20.30 0.0000
2019-11-14 2019-09-30 13F TOCAGEN COM 888846102 1,004,117 -64,018 -5.99 665 -90.68 0.0000
2019-08-14 2019-06-30 13F TOCAGEN COM 888846102 1,068,135 6,260 0.59 7,135 -38.18 0.0003
2019-05-15 2019-03-31 13F TOCAGEN COM 888846102 1,061,875 142,189 15.46 11,542 52.87 0.0005
2019-02-14 2018-12-31 13F TOCAGEN COM 888846102 919,686 132,136 16.78 7,550 -38.51 0.0003
2018-12-13 2018-09-30 13F/A-2 TOCAGEN COM 888846102 787,550 101,874 14.86 12,278 91.69 0.0005
2018-11-23 2018-09-30 13F/A-1 TOCAGEN COM 888846102 787,550 0 12,278 0.0005
2018-11-14 2018-09-30 13F TOCAGEN COM 888846102 787,550 101,874 12,278
2018-08-14 2018-06-30 13F TOCAGEN COM 888846102 685,676 14,386 2.14 6,405 -19.48 0.0003
2018-05-15 2018-03-31 13F TOCAGEN COM 888846102 671,290 23,712 3.66 7,955 19.84 0.0003
2018-02-14 2017-12-31 13F TOCAGEN COM 888846102 647,578 211,940 48.65 6,638 22.29 0.0003
2017-11-14 2017-09-30 13F TOCAGEN COM 888846102 435,638 16,942 4.05 5,428 7.78 0.0003
2017-08-24 2017-06-30 13F/A-1 TOCAGEN COM 888846102 418,696 418,696 5,036 0.0002
2017-08-11 2017-06-30 13F TOCAGEN COM 888846102 418,696 5,036 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.